North America Pharmaceutical Isolator Market – Industry Trends and Forecast to 2026

SUBSCRIBE FOR UPDATED REPORTS

Get great contents delivered straight to your inbox everyday, just a click away, Sign Up Now.
Name
Email
US : +1-888-387-2818
UK : +44 208 089 1725

North America Pharmaceutical Isolator Market – Industry Trends and Forecast to 2026

North America
Publish Reports
North America Pharmaceutical Isolator Market
  • No of pages :
    350
  • No of Figures:
    27
  • No of Tables:
    76
  • Report Type:
    Publish
  • Category:

North America Pharmaceutical Isolator Market By Type (Aseptic Isolators, Containment Isolators, Bio Isolators, Sampling and Weighing Isolators, Active Pharmaceutical Ingredient (API) Manufacturing Isolators, Others), Product Class Type (ISO Class 5, Class III), System Type (Open System, Closed System), Pressure Difference (Positive Pressure, Negative Pressure), Configuration (Floor Standing, Mobile, Compact, Modular, Table Top, Portable), Application (Sterility Testing, Pharmaceutical Industry, Microbiology Safety Cabinets, Sampling/ Weighing/ Distribution, Animal Laboratories, Medical Device Manufacturing, Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organization, Academic and Research Institutes, Hospitals, Diagnostic Laboratories), Distribution Channel (Direct Tender, Retailer), Country (U.S, Canada , Mexico) – Industry Trends and Forecast to 2026

Pharmaceutical isolators are used as an industrial barrier system to manufacture drugs in contamination free environment. The pharmaceutical isolators have various applications such as microbiological test, cell therapy processing, in production of the advanced therapy medicine products (ATMP) and in weighing, filling and dispensing of the injectable sterile products. Various companies are engaged in manufacturing the isolator for the pharmaceutical industry such as Getinge AB, Skan AG and Wabash National Corporation among others. The continuous development of the pharmaceutical market in developing and developed countries and growing research and development expenditure to develop innovative drugs are all enhancing the utilization of the pharmaceutical isolators. The advanced pharmaceutical isolators and their preferences by the pharma industries, leading the major manufactures to expand their business for the development and production of isolators. For instance, in May 2017, Skan AG (Switzerland) expanded their Germany site by constructing the production plants for the safety cabinets which is majorly engaged in manufacturing the pharmaceutical isolators.

North America pharmaceutical isolator market is projected to register a healthy CAGR of 7.9% in the forecast period 2019 to 2026.

Segmentation: North America Pharmaceutical Isolator Market

North America pharmaceutical isolator market is segmented into eight notable segments which are type, product class type, system type, pressure difference, configuration, application, end user and distribution channel.

  • On the basis of type, the market is segmented into aseptic isolators, containment isolators, bio isolators, sampling and weighing isolators, active pharmaceutical ingredient (API) manufacturing isolators and others. Aseptic isolators are growing at the highest CAGR in the forecast period of 2019 to 2026.
    • In January 2014, Extract Technology (U.K.) launched the containment and aseptic isolators, with the affordable range of systems to maintain the standard processing in the pharmaceutical, bio-tech, chemical and healthcare industry. The standard range of products SteriPharm, IsoPharm and FlexiPharm ensures high quality of manufacturing processing.
  • On the basis of product class type, the market is segmented into Class III and ISO Class 5. ISO Class 5 segment is growing at the highest CAGR in the forecast period of 2019 to 2026.
    • NuAire (US.), offers an ISO class 5 which includes the containment pharmacy isolator creates negative pressure recirculating ISO Class 5 clean air environment for aseptic compounding of hazardous drugs and minute quantities of chemotherapy drugs to meet USP 797 requirements.
  • On the basis of system type, the market is segmented into closed system and open system. Open system segment is growing at the highest CAGR in the forecast period of 2019 to 2026.
    • COMECER S.p.A. (Italy) provides an open system containment solutions which are developed for the brand new glove correctly mounted with a calibrated hole device connected.
  • On the basis of pressure difference, the market is segmented into positive pressure and negative pressure. Positive pressure is growing at the highest CAGR in the forecast period of 2019 to 2026.
    • Tema Sinergie (Italy) offers a positive pressure, custom, controlled atmosphere which includes the aseptic processing isolator system (AP-IS) is a GMP Class-A ISO 5 modular isolator system, which is basically designed for pharmaceutical production, pharmacies, quality control lab.
  • On the basis of configuration, the market is segmented into floor standing, modular, mobile, compact, table top and portable. Mobile segment is growing at the highest CAGR in the forecast period of 2019 to 2026.
    • Dec Group (Switzerland) provides DEC Multi-Purpose Isolator which is designed for the pharmaceutical product manufacturing of APIs and are containment based isolators to ensure APIs egress.
  • On the basis of application, the market is segmented into sterility testing, pharmaceutical industry, microbiology safety cabinets, sampling/ weighing/ distribution, animal laboratories, medical device manufacturing and others. Pharmaceutical industry segment is growing at the highest CAGR in the forecast period of 2019 to 2026.
    • ITECO s.r.l (Italy) provides the sterility testing isolators, SEI line ISOLATORS – STERILITY, the isolator basically designed for the mounting systems for performing sterility tests in which sterility conditions are maintained and monitored. The chamber is laminar flow (ULPA Filter, class ISO 5, U16), pneumatic gaskets, door interlocking, alarms to prevent the internal areas from contamination. It is used for the H2O2 measurement. The SEI model 702.5L insulator gives a pre-chamber and working chamber, which is designed to work in sterile conditions to eliminate the risk of contamination of the products or samples handled in them.
  • On the basis of end user, the market is segmented into hospitals, diagnostic laboratories, academic and research institutes, pharmaceutical and biotechnology companies and contract research organization. Pharmaceutical and biotechnology companies segment is growing at the highest CAGR in the forecast period of 2019 to 2026.
    • Tailin (China) provides an RT1600DTC Rigid Isolator which is the new generation turbulent air flow isolator. The product is used in sterility testing in the R&D and pharmaceutical labs.
  • On the basis of distribution channel, the market is segmented into direct tender and retailer. Direct tender is growing at the highest CAGR in the forecast period of 2019 to 2026.
    • In January 2019, TEMA SINERGIE S.p.A setup the Active Bio-decon Pass with the Chamber (AB-PTC) with an integrated vaporised hydrogen peroxide bio-decontamination system to AJ Vaccines (Denmark) for vaccine production. The establishment of the aseptic laboratory for AJ Vaccines (Denmark) enhancing the growth of the company.

Competitive Analysis: North America Pharmaceutical Isolator Market

Some of the major players operating in this market are Getinge AB, Chiyoda Corporation, Azbil Corporation, Germfree, MBRAUN, Wabash National Corporation, NuAire, ITECO s.r.l., COMECER S.p.A., Hosokawa, Hecht Technologie GmbH, Steriline S.r.l., Envair Limited, Vanrx Pharmasystems Inc., TEMA SINERGIE S.p.A, SKAN AG, Bioquell Inc., I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A., JACOMEX, Fedegari Autoclavi S.p.A, among others.

Recent Developments:

  • In January 2019, Extract Technology has announced that Terra Asia Consulting Pte. Ltd. (TAC) has been appointed as an exclusive agent for South East Asia. This expansion will create a strong geographical presence.
  • In February 2018, SKAN AG announced that collaboration agreement with FARMA ALIMENTA (Spain).This collaboration will boost the position within the Spanish market. Making new contacts with companies and to work on new interesting projects according to SKAN’s.
  • In May 2018, COMECER S.p.A. announced the new agreement with the Advaxis, Inc (U.S.) for the production of aseptic systems for the manufacturing process and for the development of the immunotherapy. The new agreement between the companies forcing the R&D of the Comecer for isolation technology.
  • In November 2018, Bioquell Inc (U.S.) highlighted their wide advanced bio-decontamination solutions designed for the pharmaceutical industry. The advanced decontamination solution works for 24/7 and eliminates pathogen immediately.
  • In May 2018, Azbil Telstar, S.L. (Spain) showcase their product at Achema exhibition held in Germany. The company will show case their latest analytical technologies for pharmaceutical freeze drying systems and aseptic manufacturing processes.
  • In July 2017, Extract Technology Limited and CPi Technology have announced that CPi Technology have been chosen as exclusive strategic agent in Ireland. This expansion will create strong geographical presence leading to growth of the company.
  • In September 2017, SKAN has announced that new business partnership with ITS Group (France). This partnership cooperation SKAN will increase and strengthen its presence in the field of isolator technology in Singapore and Indonesia.

Research Methodology: North America Pharmaceutical Isolator Market

Primary Respondents:

Key Opinion Leaders (KOL’s): Manufacturers, Researchers, Distributors and Pharmacologist, Industrialists.

Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.

Choose Licence Type

Enterprise, Single User

TABLE OF CONTENTS NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 DBMR VENDOR SHARE ANALYSIS
2.9 MULTIVARIATE MODELING
2.10 PRODUCTS LIFELINE CURVE
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 GROWING DEMAND FOR THE PHARMACEUTICAL ISOLATORS ACROSS BOOMING PHARMACEUTICAL SECTOR/INDUSTRY
3.1.2 LOW OPERATIONAL COST OF PHARMACEUTICAL ISOLATORS
3.1.3 INCREASING REGULATIONS AND COST OF NONCOMPLIANCE
3.1.4 HIGH MAINTENANCE OF ASEPTIC CONDITION IN THE PRODUCTION OF PHARMACEUTICAL PRODUCTS

3.2 RESTRAINT

3.2.1 STRINGENT GOVERNMENTAL REGULATIONS

3.3 OPPORTUNITIES

3.3.1 TECHNOLOGICAL ADVANCEMENTS IN PHARMACEUTICAL ISOLATORS
3.3.2 BUSINESS EXPANSION FOR THE PHARMACEUTICAL ISOLATORS

3.4 CHALLENGE

3.4.1 AVAILABILITY OF RESTRICTED ACCESS BARRIER SYSTEMS (RABS) FOR ASEPTIC PROCESSING

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 INDUSTRY INSIGHTS

7 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE

7.1 OVERVIEW
7.2 ASEPTIC ISOLATORS
7.3 CONTAINMENT ISOLATORS
7.4 BIO ISOLATORS
7.5 SAMPLING AND WEIGHING ISOLATORS
7.6 ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING ISOLATORS
7.7 OTHERS

8 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE

8.1 OVERVIEW
8.2 CLASS III
8.3 ISO CLASS 5

9 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE

9.1 OVERVIEW
9.2 CLOSED SYSTEM
9.3 OPEN SYSTEM

10 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE

10.1 OVERVIEW
10.2 POSITIVE PRESSURE
10.3 NEGATIVE PRESSURE

11 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION

11.1 OVERVIEW
11.2 FLOOR STANDING
11.3 MOBILE
11.4 COMPACT
11.5 MODULAR
11.6 TABLE TOP
11.7 PORTABLE

12 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION

12.1 OVERVIEW
12.2 STERILITY TESTING
12.3 PHARMACEUTICAL INDUSTRY
12.4 MICROBIOLOGY SAFETY CABINETS
12.5 SAMPLING/ WEIGHING/ DISTRIBUTION
12.6 ANIMAL LABORATORIES
12.7 MEDICAL DEVICE MANUFACTURING
12.8 OTHERS

13 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY END USER

13.1 OVERVIEW
13.2 HOSPITALS
13.3 DIAGNOSTIC LABORATORIES
13.4 ACADEMIC AND RESEARCH INSTITUTES
13.5 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
13.6 CONTRACT RESEARCH ORGANIZATION

14 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL

14.1 OVERVIEW
14.2 DIRECT TENDER
14.3 RETAILER

15 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY GEOGRAPHY

15.1 NORTH AMERICA

15.1.1 U.S.
15.1.2 CANADA
15.1.3 MEXICO

16 NORTH AMERICA PHARMACEUTICAL ISOLATORS MARKET, COMPANY LANDSCAPE

16.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

17 COMPANY PROFILE

17.1 SKAN AG

17.1.1 COMPANY SNAPSHOT
17.1.2 SWOT ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 GEOGRAPHICAL PRESENCE
17.1.5 PRODUCT PORTFOLIO
17.1.6 RECENT DEVELOPMENTS
17.1.7 DATA BRIDGE MARKET RESEARCH ANALYSIS

17.2 COMECER S.P.A.

17.2.1 COMPANY SNAPSHOT
17.2.2 SWOT ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 GEOGRAPHICAL PRESENCE
17.2.5 PRODUCT PORTFOLIO
17.2.6 RECENT DEVELOPMENTS
17.2.7 DATA BRIDGE MARKET RESEARCH ANALYSIS

17.3 GETINGE AB.

17.3.1 COMPANY SNAPSHOT
17.3.2 SWOT ANALYSIS
17.3.3 REVENUE ANALYSIS
17.3.4 COMPANY SHARE ANALYSIS
17.3.5 GEOGRAPHICAL PRESENCE
17.3.6 PRODUCT PORTFOLIO
17.3.7 RECENT DEVELOPMENTS
17.3.8 DATA BRIDGE MARKET RESEARCH ANALYSIS

17.4 WABASH NATIONAL CORPORATION

17.4.1 COMPANY SNAPSHOT
17.4.2 SWOT ANALYSIS
17.4.3 REVENUE ANALYSIS
17.4.4 COMPANY SHARE ANALYSIS
17.4.5 GEOGRAPHICAL PRESENCE
17.4.6 PRODUCT PORTFOLIO
17.4.7 RECENT DEVELOPMENTS
17.4.8 DATA BRIDGE MARKET RESEARCH ANALYSIS

17.5 A. ROVANA LTD.

17.5.1 COMPANY SNAPSHOT
17.5.2 PRODUCT PORTFOLIO
17.5.3 RECENT DEVELOPMENTS

17.6 AZBIL CORPORATION

17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 GEOGRAPHICAL PRESENCE
17.6.4 PRODUCT PORTFOLIO
17.6.5 RECENT DEVELOPMENTS

17.7 BIOQUELL INC

17.7.1 COMPANY SNAPSHOT
17.7.2 GEOGRAPHICAL PRESENCE
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENTS

17.8 CHIYODA CORPORATION

17.8.1 COMPANY SNAPSHOT
17.8.2 REVENUE ANALYSIS
17.8.3 GEOGRAPHICAL PRESENCE
17.8.4 PRODUCT PORTFOLIO
17.8.5 RECENT DEVELOPMENTS

17.9 ENVAIR LIMITED

17.9.1 COMPANY SNAPSHOT
17.9.2 GEOGRAPHICAL PRESENCE
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENTS

17.10 ESCO GROUP OF COMPANIES

17.10.1 COMPANY SNAPSHOT
17.10.2 GEOGRAPHICAL PRESENCE
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENT

17.11 FEDEGARI AUTOCLAVI S.P.A

17.11.1 COMPANY SNAPSHOT
17.11.2 GEOGRAPHICAL PRESENCE
17.11.3 PRODUCT PORTFOLIO
17.11.4 RECENT DEVELOPMENT

17.12 GERMFREE

17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENTS

17.13 HECHT TECHNOLOGIE GMBH

17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENTS

17.14 HOSOKAWA

17.14.1 COMPANY SNAPSHOT
17.14.2 REVENUE ANALYSIS
17.14.3 GEOGRAPHICAL PRESENCE
17.14.4 PRODUCT PORTFOLIO
17.14.5 RECENT DEVELOPMENTS

17.15 ITECO S.R.L.

17.15.1 COMPANY SNAPSHOT
17.15.2 GEOGRAPHICAL PRESENCE
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENTS

17.16 I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A.

17.16.1 COMPANY SNAPSHOT
17.16.2 REVENUE ANALYSIS
17.16.3 GEOGRAPHICAL PRESENCE
17.16.4 PRODUCT PORTFOLIO
17.16.5 RECENT DEVELOPMENT

17.17 JACOMEX

17.17.1 COMPANY SNAPSHOT
17.17.2 GEOGRAPHICAL PRESENCE
17.17.3 PRODUCT PORTFOLIO
17.17.4 RECENT DEVELOPMENTS

17.18 MBRAUN

17.18.1 COMPANY SNAPSHOT
17.18.2 GEOGRAPHICAL PRESENCE
17.18.3 PRODUCT PORTFOLIO
17.18.4 RECENT DEVELOPMENTS

17.19 NUAIRE

17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENT

17.20 OPTIMA PACKAGING GROUP GMBH / METALL+PLASTIC GMBH

17.20.1 COMPANY SNAPSHOT
17.20.2 GEOGRAPHICAL PRESENCE
17.20.3 PRODUCT PORTFOLIO
17.20.4 RECENT DEVELOPMENTS

17.21 ROBERT BOSCH GMBH

17.21.1 COMPANYSNAPSHOT
17.21.2 REVENUE ANALYSIS
17.21.3 GEOGRAPHICAL PRESENCE
17.21.4 PRODUCT PORTFOLIO
17.21.5 RECENT DEVELOPMENTS

17.22 STERILINE S.R.L.

17.22.1 COMPANY SNAPSHOT
17.22.2 PRODUCT PORTFOLIO
17.22.3 RECENT DEVELOPMENTS

17.23 TAILIN

17.23.1 COMPANY SNAPSHOT
17.23.2 PRODUCT PORTFOLIO
17.23.3 RECENT DEVELOPMENTS

17.24 TEMA SINERGIE S.P.A

17.24.1 COMPANY SNAPSHOT
17.24.2 PRODUCT PORTFOLIO
17.24.3 RECENT DEVELOPMENTS

17.25 VANRX PHARMASYSTEMS INC.

17.25.1 COMPANY SNAPSHOT
17.25.2 PRODUCT PORTFOLIO
17.25.3 RECENT DEVELOPMENTS

18 CONCLUSION

19 QUESTIONNAIRE

20 RELATED REPORTS

LIST OF TABLES NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET

TABLE 1 OPERATING COSTS FOR ASEPTIC PRODUCTION UNDER RABS OR ISOLATOR

TABLE 2 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE , 2017-2026 (USD MILLION)

TABLE 3 NORTH AMERICA ASEPTIC ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 4 NORTH AMERICA CONTAINMENT ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 5 NORTH AMERICA BIO ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 6 NORTH AMERICA SAMPLING AND WEIGHING ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 7 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING ISOLATORS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 8 NORTH AMERICA OTHERS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 9 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE , 2017-2026 (USD MILLION)

TABLE 10 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, BY VOLUME, 2017-2026 (THOUSANDS UNIT)

TABLE 11 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, BY ASP, 2017-2026 (USD)

TABLE 12 NORTH AMERICA CLASS III IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 NORTH AMERICA ISO CLASS 5 IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 14 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)

TABLE 15 NORTH AMERICA CLOSED SYSTEM IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 16 NORTH AMERICA OPEN SYSTEM IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)

TABLE 18 NORTH AMERICA POSITIVE PRESSURE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 19 NORTH AMERICA NEGATIVE PRESSURE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 20 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)

TABLE 21 NORTH AMERICA FLOOR STANDING IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 22 NORTH AMERICA MOBILE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 NORTH AMERICA COMPACT IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 24 NORTH AMERICA MODULAR IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 25 NORTH AMERICA TABLE TOP IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 26 NORTH AMERICA PORTABLE IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 27 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 28 NORTH AMERICA STERILITY TESTING IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 29 NORTH AMERICA PHARMACEUTICAL INDUSTRY IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 30 NORTH AMERICA MICROBIOLOGY SAFETY CABINETS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 31 NORTH AMERICA SAMPLING/ WEIGHING/ DISTRIBUTION IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 NORTH AMERICA ANIMAL LABORATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 33 NORTH AMERICA MEDICAL DEVICE MANUFACTURING IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 34 NORTH AMERICA OTHERS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 35 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY END USER , 2017-2026 (USD MILLION)

TABLE 36 NORTH AMERICA HOSPITALS IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 37 NORTH AMERICA DIAGNOSTIC LABORATORIES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 38 NORTH AMERICA ACADEMIC AND RESEARCH INSTITUTES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 39 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 40 NORTH AMERICA CONTRACT RESEARCH ORGANIZATION IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 41 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 42 NORTH AMERICA DIRECT TENDER IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 43 NORTH AMERICA RETAILER IN PHARMACEUTICAL ISOLATOR MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 44 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY COUNTRY, 2017-2026 (USD MILLION)

TABLE 45 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 46 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)

TABLE 47 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)

TABLE 48 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)

TABLE 49 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)

TABLE 50 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 51 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 52 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 53 U.S PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 54 U.S PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)

TABLE 55 U.S PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE , 2017-2026 (USD MILLION)

TABLE 56 U.S PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)

TABLE 57 U.S PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)

TABLE 58 U.S PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 59 U.S PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 60 U.S PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 61 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 62 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)

TABLE 63 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)

TABLE 64 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)

TABLE 65 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)

TABLE 66 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 67 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 68 CANADA PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 69 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 70 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY PRODUCT CLASS TYPE, 2017-2026 (USD MILLION)

TABLE 71 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE, 2017-2026 (USD MILLION)

TABLE 72 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE DIFFERENCE, 2017-2026 (USD MILLION)

TABLE 73 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION, 2017-2026 (USD MILLION)

TABLE 74 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 75 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 76 MEXICO PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

LIST OF FIGURES NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET

FIGURE 1 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: GEOGRAPHICAL SCOPE

FIGURE 3 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: DATA TRIANGULATION

FIGURE 4 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: DROC ANALYSIS

FIGURE 5 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: NORTH AMERICA VS REGIONAL ANALYSIS

FIGURE 6 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 7 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: INTERVIEWS BY REGION AND DESIGNATION

FIGURE 8 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: DBMR VENDOR SHARE ANALYSIS

FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET

FIGURE 11 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: MARKET SEGMENTATION

FIGURE 12 GROWING DEMAND FOR THE PHARMACEUTICAL ISOLATORS ACROSS BOOMING PHARMACEUTICAL AND HIGH MAINTAINACE OF ASEPTIC CONDITION IN THE PRODUCTION OF PHARMACEUTICAL PRODUCTS ARE EXPECTED TO DRIVE THE NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET IN THE FORECAST PERIOD O 2019 TO 2026

FIGURE 13 ASEPTIC ISOLATOR IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET IN 2019 & 2026

FIGURE 14 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY TYPE , 2018

FIGURE 15 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY PRODUCT CLASS TYPE, 2018

FIGURE 16 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY SYSTEM TYPE, 2018

FIGURE 17 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY PRESSURE DIFFERENCE, 2018

FIGURE 18 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY CONFIGURATION, 2018

FIGURE 19 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY APPLICATION, 2018

FIGURE 20 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY END USER, 2018

FIGURE 21 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY DISTRIBUTION CHANNEL, 2018

FIGURE 22 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: SNAPSHOT (2018)

FIGURE 23 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018)

FIGURE 24 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2019 & 2026)

FIGURE 25 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY COUNTRY (2018 & 2026)

FIGURE 26 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET: BY TYPE (2019-2026)

FIGURE 27 NORTH AMERICA PHARMACEUTICAL ISOLATORS MARKET: COMPANY SHARE 2018 (%)

Please fill in the below form and our sales representatives will get back to you Shortly

Please fill in the below form and our sales representatives will get back to you Shortly

`